Mental health and quality of life in different obesity phenotypes: a systematic review.

Health-related quality of life Mental health Metabolic phenotype Obesity phenotype

Journal

Health and quality of life outcomes
ISSN: 1477-7525
Titre abrégé: Health Qual Life Outcomes
Pays: England
ID NLM: 101153626

Informations de publication

Date de publication:
19 Apr 2022
Historique:
received: 23 02 2022
accepted: 12 04 2022
entrez: 20 4 2022
pubmed: 21 4 2022
medline: 22 4 2022
Statut: epublish

Résumé

It has been suggested that obesity phenotypes are related to mental health problems and health-related quality of life (HRQoL). However, there is no certain consensus. This systematic review aimed to evaluate the association between different obesity phenotypes with common psychiatric symptoms and HRQoL. Electronic databases i.e. PubMed, Scopus, EMBASE, and google scholar were searched until September 2021, to identify studies that investigated associations between the obesity phenotypes with psychiatric symptoms and/or mental and physical HRQoL. Two researchers independently checked titles and abstracts, evaluated full-text studies, extracted data, and appraised their quality using the Newcastle-Ottawa Scale. Eighteen studies, with a total of 3,929,203 participants, were included. Of the studies included in this systematic review, 10 articles evaluated the association between obesity phenotypes and psychiatric symptoms, while six papers investigated the association between HRQoL and obesity phenotypes, and two studies assessed both. As a whole, the findings of these studies suggest that obese individuals with a favorable metabolic profile have a slightly higher risk of mental health problems and poor quality of life, however, the risk becomes larger when obesity is combined with an adverse metabolic profile. So, metabolically healthy obesity may not be a completely benign condition in relation to mental disorders and poor quality of life. According to published research, obesity is likely to increase the risk of mental health problems and poor quality of life when metabolic disturbances are present.

Identifiants

pubmed: 35439997
doi: 10.1186/s12955-022-01974-2
pii: 10.1186/s12955-022-01974-2
pmc: PMC9019986
doi:

Types de publication

Letter Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

63

Informations de copyright

© 2022. The Author(s).

Références

Clin Nutr. 2017 Jun;36(3):853-860
pubmed: 27184975
Mol Psychiatry. 2012 Sep;17(9):940-5
pubmed: 22525487
PLoS One. 2014 Jan 29;9(1):e87657
pubmed: 24489946
J Affect Disord. 2015 Dec 1;188:14-21
pubmed: 26340078
J Clin Endocrinol Metab. 2004 Jun;89(6):2569-75
pubmed: 15181025
BMC Public Health. 2012 Feb 24;12:143
pubmed: 22364437
Am J Epidemiol. 2006 Jan 1;163(1):1-8
pubmed: 16269577
Qual Life Res. 2011 May;20(4):583-92
pubmed: 21063785
Diabetes Care. 2010 Nov;33(11):2457-61
pubmed: 20699434
Ann N Y Acad Sci. 2006 Nov;1083:329-44
pubmed: 17148748
Eur J Nutr. 2013 Feb;52(1):307-16
pubmed: 22406906
PLoS One. 2017 Apr 6;12(4):e0174678
pubmed: 28384219
Diabetes Care. 2010 May;33(5):1128-33
pubmed: 20185745
Br Med J. 1976 Jan 3;1(6000):7-9
pubmed: 1247732
Int J Geriatr Psychiatry. 2008 Apr;23(4):401-8
pubmed: 17879255
Br J Psychiatry. 2000 May;176:464-7
pubmed: 10912223
J Clin Psychiatry. 2010 Jun;71(6):729-36
pubmed: 20021996
Arch Gen Psychiatry. 2010 Mar;67(3):220-9
pubmed: 20194822
Health Qual Life Outcomes. 2008 Nov 29;6:106
pubmed: 19040759
Front Endocrinol (Lausanne). 2017 Nov 10;8:292
pubmed: 29176959
Psychoneuroendocrinology. 2018 May;91:55-61
pubmed: 29525586
J Res Med Sci. 2011 Mar;16(3):254-61
pubmed: 22091241
Int J Clin Pract. 2009 May;63(5):735-41
pubmed: 19392923
Metabolism. 2019 Mar;92:6-10
pubmed: 30253139
Obesity (Silver Spring). 2008 Jan;16(1):59-63
pubmed: 18223613
Psychoneuroendocrinology. 2015 Dec;62:47-53
pubmed: 26232649
Int J Environ Res Public Health. 2020 Dec 23;18(1):
pubmed: 33374826
Metab Syndr Relat Disord. 2020 Sep;18(7):347-352
pubmed: 32429802
Diabetes Care. 2012 May;35(5):1171-80
pubmed: 22517938
Int J Endocrinol. 2012;2012:380902
pubmed: 22675350
Neurobiol Aging. 2011 Feb;32(2):336-43
pubmed: 19329228
Clin Psychol Rev. 2011 Dec;31(8):1239-46
pubmed: 21963669
BMC Psychiatry. 2021 Mar 4;21(1):124
pubmed: 33663426
Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3463-8
pubmed: 25733901
Syst Rev. 2021 Mar 29;10(1):89
pubmed: 33781348
Transl Psychiatry. 2015 Mar 03;5:e518
pubmed: 25734511
Nutrients. 2016 Nov 25;8(12):
pubmed: 27897994
Front Endocrinol (Lausanne). 2021 May 13;12:667773
pubmed: 34054732
Am J Geriatr Psychiatry. 1998 Summer;6(3):248-56
pubmed: 9659957
J Affect Disord. 2021 Sep 1;292:369-374
pubmed: 34139410
PLoS One. 2018 Sep 12;13(9):e0203028
pubmed: 30208087
Mol Psychiatry. 2014 Aug;19(8):910-4
pubmed: 24296976
Int J Obes (Lond). 2011 Aug;35(8):1087-94
pubmed: 21042326
Diabetes Care. 2001 Jun;24(6):1069-78
pubmed: 11375373
Health Qual Life Outcomes. 2017 Jun 10;15(1):122
pubmed: 28601090
J Womens Health (Larchmt). 2010 Jun;19(6):1201-7
pubmed: 20482255
Mol Psychiatry. 2013 Sep;18(9):963-74
pubmed: 23439482
Biol Psychiatry. 2010 Mar 1;67(5):446-57
pubmed: 20015486
J Hypertens. 2008 Sep;26(9):1765-72
pubmed: 18698210
Int Arch Occup Environ Health. 2021 May;94(4):639-646
pubmed: 33245393
Med J Islam Repub Iran. 2018 Oct 01;32:95
pubmed: 30788332
Br J Psychiatry. 2008 Aug;193(2):108-13
pubmed: 18669991
Soc Psychiatry Psychiatr Epidemiol. 2018 Jun;53(6):639-646
pubmed: 29675748
Obes Rev. 2018 Nov;19(11):1557-1568
pubmed: 30047228
Psychiatry Res. 2009 Aug 15;168(3):218-21
pubmed: 19560828
J Psychiatr Res. 1998 Nov-Dec;32(6):403-10
pubmed: 9844957
Int J Obes (Lond). 2006 Aug;30(8):1250-9
pubmed: 16520814
Obesity (Silver Spring). 2010 Oct;18(10):1981-7
pubmed: 20075853
Obesity (Silver Spring). 2010 May;18(5):1033-8
pubmed: 19816409
Qual Life Res. 2009 Dec;18(10):1293-9
pubmed: 19813103
Int J Obes Relat Metab Disord. 1992 Dec;16(12):999-1003
pubmed: 1335980
Qual Life Res. 2016 Jun;25(6):1537-48
pubmed: 26615614
Front Aging Neurosci. 2021 Aug 02;13:618623
pubmed: 34408637

Auteurs

Behnaz Abiri (B)

Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Farhad Hosseinpanah (F)

Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Seyedshahab Banihashem (S)

Taleghani Hospital Research Development Committee (Taleghani-HRDC), Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Seyed Ataollah Madinehzad (SA)

Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Majid Valizadeh (M)

Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. valizadeh@endocrine.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH